Bioventus Inc. (BVS)
7.69
-0.04 (-0.52%)
At close: Apr 25, 2025, 3:59 PM
7.90
2.73%
After-hours: Apr 25, 2025, 05:32 PM EDT
Bioventus Revenue Breakdown
| Period Ending | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 |
|---|---|---|---|
| International Segment Revenue | 16.05M | 16.81M | 15.18M |
| International Segment Revenue Growth | -4.48% | +10.75% | n/a |
| U.S. Segment Revenue | 122.91M | 134.41M | 114.28M |
| U.S. Segment Revenue Growth | -8.56% | +17.61% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Non-Us Revenue | 62.48M | 14.95M | 43.34M |
| Non-Us Revenue Growth | +317.93% | -65.51% | n/a |
| United States Revenue | 449.86M | 126.21M | 387.55M |
| United States Revenue Growth | +256.45% | -67.43% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 29, 2019 | Mar 31, 2016 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 81.09M | 91.94M | 77.84M | 76.68M | 69.82M | 74.84M | 80.86M | 77.67M | 78.95M | 89.62M | 86.12M | 80.88M | 69.64M | 69.05M | 34.69M | 61.97M | 50.3M | 40.53M | 40.28M | 54.45M | 45.12M | 49.45M | 49.45M | 40.18M | 37.27M |
| Selling, General, and Administrative Revenue Growth | -11.80% | +18.11% | +1.51% | +9.83% | -6.71% | -7.44% | +4.11% | -1.63% | -11.90% | +4.06% | +6.48% | +16.15% | +0.85% | +99.07% | -44.03% | +23.22% | +24.08% | +0.64% | -26.04% | +20.69% | -8.76% | 0.00% | +23.06% | +7.82% | n/a |
| Research and Development Revenue | 3.81M | 3.99M | 2.6M | 3.26M | 3.02M | 3.4M | 3.77M | 6.81M | 4.61M | 6.37M | 6.93M | 7.1M | 6.15M | 4.84M | 947K | 2.89M | 3.57M | 2.6M | 2.15M | 3.14M | 2.85M | 2.53M | 2.53M | 3.72M | 2.97M |
| Research and Development Revenue Growth | -4.51% | +53.56% | -20.39% | +8.19% | -11.27% | -9.89% | -44.60% | +47.53% | -27.52% | -8.11% | -2.46% | +15.44% | +27.23% | +410.67% | -67.24% | -19.00% | +37.48% | +20.97% | -31.74% | +10.35% | +12.56% | 0.00% | -31.93% | +25.35% | n/a |